<tablegroup Reference="ref" id="id68-----39-----BCMA;17-001511;-20C;INVERTED">
  <h3 tableHeader="yes">0.0.0.0.0-3. Drug Product Stability Long-Term Batch 17-001511 for -20C</h3>
  <table border="1" width="100%" pagebreak="true" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1" parent_tablegroup="id68-----39-----BCMA;17-001511;-20C;INVERTED" class="output-table" seq="1">
    <tr>
      <th rowSpan="2" style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----Time (Months)___Time (Months)-----Time (Months)">Time (Months)</th>
      <th style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----AEX-HPLC___ANTI-CD3 MAB-----AEX-HPLC">AEX-HPLC</th>
      <th colSpan="3" style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----APPEARANCE___CLARITY-----Appearance">Appearance</th>
      <th style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY-----Biological Activity (Binding ELISA)">Biological Activity (Binding ELISA)</th>
      <th colSpan="2" style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CEX-HPLC___ANTI-BCMA MAB-----CEX-HPLC">CEX-HPLC</th>
      <th colSpan="3" style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CGE (NON-REDUCING)___FRAGMENTS-----CGE (non-reducing)">CGE (non-reducing)</th>
      <th colSpan="3" style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CGE (REDUCING)___FRAGMENTS-----CGE (reducing)">CGE (reducing)</th>
      <th rowSpan="2" style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----ENDOTOXIN___ENDOTOXIN-----Endotoxin">Endotoxin</th>
      <th rowSpan="2" style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----OSMOLARITY___OSMOLARITY-----Osmolarity">Osmolarity</th>
      <th style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)-----Peptide Mapping">Peptide Mapping</th>
      <th colSpan="2" style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----SE-HPLC___HMMS-----SE-HPLC">SE-HPLC</th>
      <th rowSpan="2" style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----STERILITY___STERILITY-----Sterility">Sterility</th>
      <th rowSpan="2" style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES-----Subvisible Particles">Subvisible Particles</th>
      <th colSpan="2" style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M-----Subvisible Particles">Subvisible Particles</th>
      <th style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----UV SPECTROSCOPY___PROTEIN CONCENTRATION-----UV Spectroscopy">UV Spectroscopy</th>
      <th colSpan="3" style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----ICE___ACIDIC SPECIES-----iCE">iCE</th>
      <th style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CONTAINER CLOSURE INTEGRITY___DYE INGRESS-----CCI=== Container Closure Integrity">CCI=== Container Closure Integrity</th>
      <th rowSpan="2" style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----PH___PH-----pH">pH</th>
    </tr>
    <tr>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----AEX-HPLC___ANTI-CD3 MAB-----Anti-CD3 mAb">Anti-CD3 mAb</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----APPEARANCE___CLARITY-----Clarity">Clarity</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----APPEARANCE___COLORATION-----Coloration">Coloration</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----APPEARANCE___VISIBLE PARTICULATES-----Visible Particulates">Visible Particulates</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY-----Relative Potency">Relative Potency</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CEX-HPLC___ANTI-BCMA MAB-----Anti-BCMA mAb">Anti-BCMA mAb</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CEX-HPLC___ANTI-BCMA/ANTI-CD3 BISPECIFIC CLIP-----Anti-BCMA/Anti-CD3 Bispecific Clip">Anti-BCMA/Anti-CD3 Bispecific Clip</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CGE (NON-REDUCING)___FRAGMENTS-----Fragments">Fragments</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CGE (NON-REDUCING)___INTACT IGG-----Intact IgG">Intact IgG</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CGE (NON-REDUCING)___OTHER-----Other">Other</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CGE (REDUCING)___FRAGMENTS-----Fragments">Fragments</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CGE (REDUCING)___HEAVY CHAIN + LIGHT CHAIN-----Heavy Chain + Light Chain">Heavy Chain + Light Chain</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CGE (REDUCING)___OTHER-----Other">Other</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)-----Identity (Peptide Profile)">Identity (Peptide Profile)</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----SE-HPLC___HMMS-----HMMS">HMMS</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----SE-HPLC___MONOMER-----Monomer">Monomer</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M-----Subvisible Particles &gt;= 10µm">Subvisible Particles &gt;= 10µm</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 25M-----Subvisible Particles &gt;= 25µm">Subvisible Particles &gt;= 25µm</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----UV SPECTROSCOPY___PROTEIN CONCENTRATION-----Protein Concentration">Protein Concentration</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----ICE___ACIDIC SPECIES-----Acidic Species">Acidic Species</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----ICE___BASIC SPECIES-----Basic Species">Basic Species</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----ICE___MAIN SPECIES-----Main Species">Main Species</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)-----CONTAINER CLOSURE INTEGRITY___DYE INGRESS-----Dye Ingress">Dye Ingress</th>
    </tr>
    <tr>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----Time (Months)___Time (Months)">Clinical Acceptance Criteria</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----AEX-HPLC___ANTI-CD3 MAB">&lt;= 3.0% anti CD3 parent mAb</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----APPEARANCE___CLARITY">&lt;= 18 NTU</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----APPEARANCE___COLORATION">Not more intensely colored than level 5 of the color standard</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----APPEARANCE___VISIBLE PARTICULATES">Essentially free from visible particulates</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY">50 - 150% potency relative to reference material</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CEX-HPLC___ANTI-BCMA MAB">&lt;= 3.0% anti BCMA parent mAb</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CEX-HPLC___ANTI-BCMA/ANTI-CD3 BISPECIFIC CLIP">&lt;= 5.0% Bispecific mAb Clip</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CGE (NON-REDUCING)___FRAGMENTS">&lt;= 10.0% fragments</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CGE (NON-REDUCING)___INTACT IGG">&gt;= 90.0% IgG</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CGE (NON-REDUCING)___OTHER">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CGE (REDUCING)___FRAGMENTS">-</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CGE (REDUCING)___HEAVY CHAIN + LIGHT CHAIN">-</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CGE (REDUCING)___OTHER">-</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----ENDOTOXIN___ENDOTOXIN">&lt;= 10 EU/mg</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----OSMOLARITY___OSMOLARITY">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)">Comparable to Reference</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----SE-HPLC___HMMS">&lt;= 5.0% HMMS</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----SE-HPLC___MONOMER">&gt;= 90.0% monomer</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----STERILITY___STERILITY">No growth detected</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES">Meets compendial requirements</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 25M">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----UV SPECTROSCOPY___PROTEIN CONCENTRATION">2.0 +/- 0.2 mg/mL</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----ICE___ACIDIC SPECIES">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----ICE___BASIC SPECIES">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----ICE___MAIN SPECIES">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----CONTAINER CLOSURE INTEGRITY___DYE INGRESS">---</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria-----PH___PH">5.8 +/- 0.5</th>
    </tr>
    <tr>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----Time (Months)___Time (Months)">0</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----AEX-HPLC___ANTI-CD3 MAB">0.3</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----APPEARANCE___CLARITY">1</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----APPEARANCE___COLORATION">&lt;=B9</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----APPEARANCE___VISIBLE PARTICULATES">Essentially free from visible particulates</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY">92</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CEX-HPLC___ANTI-BCMA MAB">NMT 0.1</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CEX-HPLC___ANTI-BCMA/ANTI-CD3 BISPECIFIC CLIP">0.4</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CGE (NON-REDUCING)___FRAGMENTS">0.8</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CGE (NON-REDUCING)___INTACT IGG">99.2</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CGE (NON-REDUCING)___OTHER">NMT 0.3</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CGE (REDUCING)___FRAGMENTS">0.9</td>
      <td style="width:4%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CGE (REDUCING)___HEAVY CHAIN + LIGHT CHAIN">99.1</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CGE (REDUCING)___OTHER">NMT 0.3</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----ENDOTOXIN___ENDOTOXIN">NMT 1</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----OSMOLARITY___OSMOLARITY">310</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)">Comparable to Reference</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----SE-HPLC___HMMS">0.4</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----SE-HPLC___MONOMER">99.6</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----STERILITY___STERILITY">No growth detected</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES">Meets compendial requirements</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M">5</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 25M">&lt;1</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----UV SPECTROSCOPY___PROTEIN CONCENTRATION">2.0</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----ICE___ACIDIC SPECIES">38.7</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----ICE___BASIC SPECIES">14.7</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----ICE___MAIN SPECIES">46.6</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----CONTAINER CLOSURE INTEGRITY___DYE INGRESS">---</td>
      <td style="width:3%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0-----PH___PH">5.7</td>
    </tr>
    <tr>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----Time (Months)___Time (Months)">1</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----AEX-HPLC___ANTI-CD3 MAB">0.2</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----APPEARANCE___CLARITY">2</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----APPEARANCE___COLORATION">&lt;=B9</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----APPEARANCE___VISIBLE PARTICULATES">Essentially free from visible particulates</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY">97</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CEX-HPLC___ANTI-BCMA MAB">0.2</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CEX-HPLC___ANTI-BCMA/ANTI-CD3 BISPECIFIC CLIP">0.6</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CGE (NON-REDUCING)___FRAGMENTS">0.5</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CGE (NON-REDUCING)___INTACT IGG">99.5</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CGE (NON-REDUCING)___OTHER">NMT 0.3</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CGE (REDUCING)___FRAGMENTS">0.9</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CGE (REDUCING)___HEAVY CHAIN + LIGHT CHAIN">99.1</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CGE (REDUCING)___OTHER">NMT 0.3</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----ENDOTOXIN___ENDOTOXIN">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----OSMOLARITY___OSMOLARITY">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----SE-HPLC___HMMS">0.3</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----SE-HPLC___MONOMER">99.6</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----STERILITY___STERILITY">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 25M">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----UV SPECTROSCOPY___PROTEIN CONCENTRATION">2.0</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----ICE___ACIDIC SPECIES">40.4</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----ICE___BASIC SPECIES">14.7</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----ICE___MAIN SPECIES">44.9</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----CONTAINER CLOSURE INTEGRITY___DYE INGRESS">---</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1-----PH___PH">5.8</td>
    </tr>
  </table>
  <br/>
</tablegroup>